Immusol, Inc. Announces Collaboration With Novartis Corporation (NVS)
10/19/2005 5:09:09 PM
SAN DIEGO, CA--(MARKET WIRE)--Aug 16, 2005 -- Immusol today announced a three-year discovery, development and commercialization collaboration with Novartis. The agreement has the potential to exceed $78 million in payments to Immusol contingent upon the delivery of targets and compounds and upon the successful development of these compounds by Novartis.